Related Experiment Video

Updated: Jun 5, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility

Fahd al-Mulla1, Milad S Bitar, Zainab Taqi

  • 1Department of Pathology, University of Kuwait, Faculty of Medicine, Health Sciences Center, 13110, Kuwait. fahd@al-mulla.org

Molecular Biosystems
|December 25, 2010
PubMed

Insights

RKIP-1 loss accelerates cell cycle progression and enhances cancer cell motility by altering gene expression. This suggests RKIP-1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • RKIP-1 (Raf kinase inhibitor protein) acts as a metastasis suppressor frequently downregulated in aggressive cancers.
  • The functional consequences of RKIP-1 loss in non-cancerous cells remain largely unexplored.

Purpose of the Study:

  • To investigate the cellular and molecular effects of RKIP-1 depletion in immortalized human cells.
  • To elucidate the role of RKIP-1 in regulating cell cycle kinetics and cellular motility.

Main Methods:

  • Utilized HEK-293 cells with RKIP-1 depletion (HEK-499) and inducible RKIP-1 expression.
  • Performed whole transcriptome analysis to assess gene expression changes.
  • Quantified cell cycle progression, nuclear envelope breakdown (NEB) to anaphase timing, and cellular motility.

Main Results:

  • RKIP-1 silencing accelerated DNA synthesis and G1/S phase transition by upregulating key cell cycle regulators (cdc6, MCMs, cyclins) and downregulating p21(cip1).
  • RKIP-1 depletion shortened the NEB to anaphase duration, associated with increased NEK6 and decreased G2/M checkpoint molecules (Aurora B, cyclin G1, sertuin).
  • Loss of RKIP-1 enhanced cellular motility through increased expression/stabilization of β-catenin, vimentin, MET, and PAK1.

Conclusions:

  • RKIP-1 modulates cell cycle checkpoints and cellular motility, contributing to its function as a metastasis suppressor.
  • RKIP-1 plays a complex and diverse role in cellular processes beyond its previously understood functions.

More Related Videos

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...